Simplex Trading
STSA

Simplex Trading’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Simplex Trading’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-300
Closed -$1K – 11752
2021
Q4 		$1K Sell
300
-2,700
-90% -$13.7K ﹤0.01% 10306
2021
Q3 		$20K Hold
3,000
– – ﹤0.01% 8459
2021
Q2 		$21K Buy
+3,000
New +$16.2K ﹤0.01% 8564

Simplex Trading's STSA Position: Q2 2023 in Review

Simplex Trading sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 21,864 shares — an estimated $15K sold.

Simplex Trading first reported a position in STSA in Q4 2021 and held it in 5 quarters. The position peaked at $406K in Q3 2022. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

  • Simplex Trading reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 21,864 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $15K.
  • Simplex Trading first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • Simplex Trading's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $406K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.